NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE255519 Query DataSets for GSE255519
Status Public on Feb 23, 2024
Title The interferon-rich skin environment regulates Langerhans cell ADAM17 to promote photosensitivity in lupus
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary The autoimmune disease lupus erythematosus (lupus) is characterized in part by photosensitivity, where patients can develop inflammatory skin lesions with even ambient ultraviolet radiation (UVR) exposure. Evidence points to a role for type I interferon (IFN-I) in photosensitivity, but mechanistic understanding remains limited. We have shown that photosensitivity in lupus models is at least in part attributable to Langerhans cell (LC) dysfunction. Healthy LCs limit photosensitivity via a disintegrin and metalloprotease 17 (ADAM17), a sheddase that normally limits UVR-induced skin inflammation by releasing soluble epidermal growth factor receptor (EGFR) ligands to support keratinocyte survival. On the other hand, LCs from lesional and even non-lesional lupus model skin show reduced ADAM17 activity and mRNA expression. Non-lesional human lupus skin also showed evidence of LC dysfunction, and, here, we asked how the lupus skin environment contributes to this dysfunction. We show that non-lesional skin in human CLE and multiple photosensitive lupus models share gene expression patterns consistent with a high IFN environment and LC dysfunction. IFN-I inhibits murine and human LC ADAM17 activity, and anti-IFNAR1 in lupus models restores LC ADAM17 function and reduces photosensitivity in EGFR and LC ADAM17-dependent manners. Reactive oxygen species (ROS) are a mediator of ADAM17 activity, and we show that lupus models have reduced UVR-induced LC ROS generation that is restored by anti-IFNAR1. Our findings suggest shared pathogenic mechanisms of photosensitivity in human and murine lupus skin and a model whereby the IFN-I-rich microenvironment in non-lesional lupus skin inhibits UVR-induced ADAM17 activity, predisposing to photosensitivity. Our data also suggest that the beneficial effects of the recently FDA-approved anifrolumab (anti-IFNAR1) on human lupus skin could act in part by restoring LC function.
 
Overall design Comparative gene expression profiling analysis of RNA-seq data for
 
Contributor(s) Li TM, Schwartz N, Chinenov Y, Daamen AR, Oliver DJ, Dacic M, Jabbari A, Rogatsky I, Lu TT
Citation(s) 38860651
Submission date Feb 09, 2024
Last update date Jul 31, 2024
Contact name Yurii Chinenov
Organization name Hospital for special surgery
Department Research Division
Lab HSS Genomics Center
Street address 535 E 71 str, Hospital for Special Surgery
City New york
State/province New York
ZIP/Postal code 11361
Country USA
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (19)
GSM8073688 CTRL_m17
GSM8073689 CTRL_m18
GSM8073690 CTRL_m19
Relations
BioProject PRJNA1075143

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE255519_edgeR_DEGs_MD-14749_TL_15499_batch_2024-01-22.xlsx 13.0 Mb (ftp)(http) XLSX
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap